Ticker: VIR

Vir Biotechnology, Inc. (NASDAQ: VIR) has recently reported its quarterly results for the period ending June 30, 2025. The company, which focuses on biopharmaceuticals for serious infectious diseases and cancer, shows some turmoil in its financial health reflected in its recent income statement. ...